New Age Alpha Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
New Age Alpha Advisors's CPRX Position: Q3 2026 in Review
New Age Alpha Advisors sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 4,867 shares — an estimated $153K sold.
New Age Alpha Advisors first reported a position in CPRX in Q4 2025 and held it in 3 quarters. The position peaked at $153K in Q2 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- New Age Alpha Advisors reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- New Age Alpha Advisors sold 4,867 Catalyst Pharmaceutical shares in Q3 2026, an estimated $153K.
- New Age Alpha Advisors first reported a position in Catalyst Pharmaceutical in Q4 2025 and held it in 3 quarters.
- New Age Alpha Advisors's Catalyst Pharmaceutical position peaked at $153K in Q2 2026.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on New Age Alpha Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.